BRPI0916559A2 - derivados de pirrolidinil-alquil-amida, sua preparação e sua aplicação terapêutica como ligantes receptores de ccr3 - Google Patents
derivados de pirrolidinil-alquil-amida, sua preparação e sua aplicação terapêutica como ligantes receptores de ccr3Info
- Publication number
- BRPI0916559A2 BRPI0916559A2 BRPI0916559A BRPI0916559A BRPI0916559A2 BR PI0916559 A2 BRPI0916559 A2 BR PI0916559A2 BR PI0916559 A BRPI0916559 A BR PI0916559A BR PI0916559 A BRPI0916559 A BR PI0916559A BR PI0916559 A2 BRPI0916559 A2 BR PI0916559A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- receptor ligands
- amide derivatives
- therapeutic application
- alkyl amide
- Prior art date
Links
- 102000004499 CCR3 Receptors Human genes 0.000 title 1
- 108010017316 CCR3 Receptors Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- -1 pyrrolidinyl alkyl amide Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0800478A HUP0800478A2 (en) | 2008-07-31 | 2008-07-31 | Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands |
| PCT/HU2009/000067 WO2010013078A2 (en) | 2008-07-31 | 2009-07-29 | Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0916559A2 true BRPI0916559A2 (pt) | 2015-11-10 |
Family
ID=89988430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0916559A BRPI0916559A2 (pt) | 2008-07-31 | 2009-07-29 | derivados de pirrolidinil-alquil-amida, sua preparação e sua aplicação terapêutica como ligantes receptores de ccr3 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8420636B2 (pt) |
| EP (1) | EP2318402B1 (pt) |
| JP (1) | JP5496199B2 (pt) |
| CN (1) | CN102112473B (pt) |
| AR (1) | AR072623A1 (pt) |
| AU (1) | AU2009275626B2 (pt) |
| BR (1) | BRPI0916559A2 (pt) |
| CA (1) | CA2732631A1 (pt) |
| ES (1) | ES2483767T3 (pt) |
| HR (1) | HRP20140679T1 (pt) |
| HU (1) | HUP0800478A2 (pt) |
| IL (1) | IL210827A0 (pt) |
| MX (1) | MX2011001087A (pt) |
| RU (1) | RU2514824C2 (pt) |
| TW (1) | TW201018698A (pt) |
| WO (1) | WO2010013078A2 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0800478A2 (en) | 2008-07-31 | 2010-03-01 | Sanofi Aventis | Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands |
| EP3050574B1 (en) | 2015-01-28 | 2019-10-09 | Universite De Bordeaux | Use of plerixafor for treating and/or preventing acute exacerbations of chronic obstructive pulmonary disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5767144A (en) * | 1994-08-19 | 1998-06-16 | Abbott Laboratories | Endothelin antagonists |
| AR033517A1 (es) * | 2000-04-08 | 2003-12-26 | Astrazeneca Ab | Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos |
| GB0207449D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| AU2004215679A1 (en) * | 2003-02-27 | 2004-09-10 | F. Hoffmann-La Roche Ag | CCR-3 receptor antagonists |
| CA2520225C (en) | 2003-03-24 | 2014-08-12 | Bayer Healthcare Ag | Benzenesulfonamide derivatives |
| HUP0500886A2 (en) * | 2005-09-23 | 2007-05-29 | Sanofi Aventis | Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use |
| JP2009508929A (ja) * | 2005-09-22 | 2009-03-05 | サノフイ−アベンテイス | Ｃｃｒ３受容体リガンドとしてのアミノ−アルキル−アミド誘導体 |
| HUP0800478A2 (en) | 2008-07-31 | 2010-03-01 | Sanofi Aventis | Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands |
-
2008
- 2008-07-31 HU HU0800478A patent/HUP0800478A2/hu unknown
-
2009
- 2009-07-29 WO PCT/HU2009/000067 patent/WO2010013078A2/en active Application Filing
- 2009-07-29 BR BRPI0916559A patent/BRPI0916559A2/pt not_active IP Right Cessation
- 2009-07-29 JP JP2011520604A patent/JP5496199B2/ja not_active Expired - Fee Related
- 2009-07-29 CA CA2732631A patent/CA2732631A1/en not_active Abandoned
- 2009-07-29 EP EP09785768.4A patent/EP2318402B1/en not_active Not-in-force
- 2009-07-29 AR ARP090102883A patent/AR072623A1/es not_active Application Discontinuation
- 2009-07-29 CN CN200980130148.4A patent/CN102112473B/zh not_active Expired - Fee Related
- 2009-07-29 ES ES09785768.4T patent/ES2483767T3/es active Active
- 2009-07-29 RU RU2011107205/04A patent/RU2514824C2/ru not_active IP Right Cessation
- 2009-07-29 AU AU2009275626A patent/AU2009275626B2/en not_active Ceased
- 2009-07-29 TW TW098125454A patent/TW201018698A/zh unknown
- 2009-07-29 MX MX2011001087A patent/MX2011001087A/es active IP Right Grant
-
2011
- 2011-01-23 IL IL210827A patent/IL210827A0/en unknown
- 2011-01-26 US US13/014,145 patent/US8420636B2/en not_active Expired - Fee Related
-
2014
- 2014-07-15 HR HRP20140679AT patent/HRP20140679T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010013078A2 (en) | 2010-02-04 |
| RU2011107205A (ru) | 2012-09-10 |
| HU0800478D0 (en) | 2008-09-29 |
| AR072623A1 (es) | 2010-09-08 |
| HRP20140679T1 (hr) | 2014-10-10 |
| IL210827A0 (en) | 2011-04-28 |
| HUP0800478A2 (en) | 2010-03-01 |
| JP2011529482A (ja) | 2011-12-08 |
| CA2732631A1 (en) | 2010-02-04 |
| EP2318402B1 (en) | 2014-04-30 |
| TW201018698A (en) | 2010-05-16 |
| CN102112473A (zh) | 2011-06-29 |
| RU2514824C2 (ru) | 2014-05-10 |
| AU2009275626A1 (en) | 2010-02-04 |
| US8420636B2 (en) | 2013-04-16 |
| WO2010013078A8 (en) | 2010-05-20 |
| CN102112473B (zh) | 2014-08-20 |
| EP2318402A2 (en) | 2011-05-11 |
| JP5496199B2 (ja) | 2014-05-21 |
| MX2011001087A (es) | 2011-03-29 |
| US20110144104A1 (en) | 2011-06-16 |
| WO2010013078A3 (en) | 2010-03-25 |
| ES2483767T3 (es) | 2014-08-07 |
| AU2009275626B2 (en) | 2013-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR10926A (es) | Nuevas 2-aminooxazolinas como ligandos taar1 | |
| BRPI0920514A2 (pt) | infusão de fármacos | |
| BRPI0916931A2 (pt) | agentes terapêuticos | |
| DK2242771T3 (da) | Bindingsmolekyler til den humane ox40-receptor | |
| BRPI0817562A2 (pt) | derivados de n-hidroxilsulfonamida como novos doadores de niltroxil fisiologicamente úteis | |
| BRPI0810613A2 (pt) | derivados de tetra-hidrocarbazol como ligantes de receptores acoplados à proteína g | |
| BRPI0917203A2 (pt) | Derivado de benzenodicarboxamida inseticida | |
| BRPI0918064A2 (pt) | distribuidor de substância | |
| BRPI0906532A2 (pt) | Unidade de dosagem de tintura | |
| DK2144905T3 (da) | Terapeutiske midler | |
| BRPI0721857A2 (pt) | Seringa com agulha ajustável | |
| BRPI0908050A2 (pt) | Furo-e tieno[3,2-c]piridinas | |
| BRPI0924059A2 (pt) | Didro piridona amidas como moduladores de p2x7 | |
| BRPI0915427A2 (pt) | composição farmacêutica | |
| BRPI0906357A2 (pt) | Derivados de oxazepinopirimidona arilamida substituídos | |
| BRPI0918935A2 (pt) | compostos amida úteis em terapia | |
| DK3150178T3 (da) | Stimuleringsapparat | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| BRPI0921947A2 (pt) | formulações de proteína terapêutica | |
| BRPI0907963A2 (pt) | Derivados de indazola | |
| BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
| BRPI0807913A2 (pt) | Derivado heterocíclicos como receptores muscarínicos m3 | |
| BRPI0914900A2 (pt) | compostos de amida, métodos de preparação e usos dos mesmos | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| BRPI0716742A2 (pt) | Lactamas terapêuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |